EXIT071

Leiden, The Netherlands

EXIT071 is a Netherlands-based startup developing advanced technologies for extracellular vesicle (EV) isolation and analysis.

$2.1M raised

Mar 2025

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has EXIT071 raised?

EXIT071 has raised $2.1M in total funding. The most recent round was Seed. The last funding was announced in March 2025.

Who are EXIT071's investors?

EXIT071's investors include Biotech Booster, UNIIQ, LEH.

Where is EXIT071 headquartered?

EXIT071 is headquartered in Leiden, The Netherlands.

What does EXIT071 do?

EXIT071 is a Netherlands-based startup developing advanced technologies for extracellular vesicle (EV) isolation and analysis.

What stage is EXIT071 at?

EXIT071 is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 24, 2025.

MLA

"EXIT071 — Funding & Investors." VCBacked, March 24, 2025, https://www.vcbacked.co/company/exit071. Accessed July 2, 2026.

APA

VCBacked. (2025). EXIT071 — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/exit071

Wikipedia (cite web)

{{cite web |title=EXIT071 — Funding & Investors |url=https://www.vcbacked.co/company/exit071 |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 24, 2025.